Publicacions destacades

Projectes destacats

  • Expression of Rupatadine on PAF-induced inflammation in blood eosinophils and epithelial cells from nasal polyps and healthy nasal mucosa (RINOPAF-2 Study).

    Investigador/a principal: Joaquim Mullol I Miret
    Finançador: URIACH S.A
    Codi: RINOPAF-02-2018
    Durada: 01/01/2019 - 31/12/2021
  • El impacto de la inflamación sobre el sentido del olfato en pacientes con poliposis nasal: El rol de los eosinófilos sobre la neurogenesis del neuroepitelio olfatorio.

    Investigador/a principal: Isam Alobid
    Finançador: Fundació Privada Clínic per a la Recerca Biomèdica (Sede o evento); Fondo Investigaciones Sanitarias (FIS)
    Codi: (PI15/00262)
    Durada: 01/01/2016 - 31/12/2019
  • Study of the antiinflammatory mechanisms of action of MP29-02, compared to fluticasone propionate and azelastine alone, in healthy and inflamed human ansal mucosa: regulation on anti- and pro-inflammatory genes and GR.

    Investigador/a principal: Joaquim Mullol I Miret
    Finançador: MEDA Pharma
    Codi: DYMECOS II
    Durada: 01/01/2016 - 31/12/2019
  • Randomized double-blind, phase III, placebo controlled, to evaluate dupilumab in patients with bilateral nasal polyposis and symptoms of chronic sinusitis.

    Finançador: Sanofi Aventis, S.A. ; CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Participante)
    Durada: 01/01/2016
  • Randomized double-blind, phase II, placebo controlled, 2 arm study to evaluate dupilumab in patients with bilateral nasal polyposis and symptoms of chronic sinusitis.

    Finançador: Sanofi Aventis, S.A. ; CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Participante)
    Durada: 01/01/2014